Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Plos One|June 1, 2013
How to improve the implementation of academic clinical pediatric trials involving drug therapy? A qualitative study of multiple stakeholdersDelphine Girard, Olivier Bourdon, Hendy Abdoul, et al.
BMC Medical Research Methodology|March 31, 2016
Academic pediatric clinical research: factors associated with study implementation durationDelphine Meier-Girard, Annick Tibi, Hendy Abdoul, et al.
Antiviral Therapy|August 23, 2012
Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in householdsFabrice Carrat, Xavier Duval, Florence Tubach, et al.
BMJ Open|July 13, 2017
Factors associated with non-persistence to oral and inhaled antiviral therapies for seasonal influenza: a secondary analysis of a double-blind, multicentre, randomised clinical trialRemi Flicoteaux, Camelia Protopopescu, Annick Tibi, et al.
Cancer Science|June 23, 2015
Immunotherapy with CpG-ODN in neoplastic meningitis: A phase I trialRenata Ursu, Sophie Taillibert, Claire Banissi, et al.
Eclinicalmedicine|September 26, 2022
Effect of intravenous almitrine on intubation or mortality in patients with COVID-19 acute hypoxemic respiratory failure: A multicentre, randomised, double-blind, placebo-controlled trialPierre Kalfon, Jean-François Payen, Alexandra Rousseau, et al.
European Journal of Cancer (Oxford, England : 1990)|February 1, 2017
Intracerebral injection of CpG oligonucleotide for patients with de novo glioblastoma-A phase II multicentric, randomised studyRenata Ursu, Alexandre Carpentier, Philippe Metellus, et al.
Plos Medicine|November 13, 2010
Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trialXavier Duval, Sylvie van der Werf, Thierry Blanchon, et al.
Neuro-Oncology|January 31, 2006
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastomaAlexandre Carpentier, Florence Laigle-Donadey, Sarah Zohar, et al.
Neuro-Oncology|March 24, 2010
Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II studyAlexandre Carpentier, Philippe Metellus, Renata Ursu, et al.
Pageof 2